scispace - formally typeset
J

James C. Reading

Researcher at University of Utah

Publications -  82
Citations -  5422

James C. Reading is an academic researcher from University of Utah. The author has contributed to research in topics: Rheumatoid arthritis & Placebo. The author has an hindex of 34, co-authored 82 publications receiving 5290 citations. Previous affiliations of James C. Reading include University of Alabama at Birmingham & Saft Groupe S.A..

Papers
More filters
Journal ArticleDOI

Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

H. James Williams, +13 more
- 01 Jul 1985 - 
TL;DR: Patients able to tolerate low-dose pulse MTX therapy were significantly improved, compared with patients receiving placebo therapy, for all clinical variables measured, including joint pain/tenderness and swelling counts, rheumatoid nodules, and patient and physician assessment of disease activity.
Journal Article

Type 2 diabetes mellitus in Canada‚s First Nations: status of an epidemic in progress

T K Young, +3 more
- 05 Sep 2000 - 
TL;DR: The epidemic of type 2 diabetes mellitus in Canada's First Nations is still on the upswing, with a trend toward earlier age at onset, and genetic-environmental interactions are the likely cause.
Journal ArticleDOI

Risk factors for postoperative pneumonia

Richard A. Garibaldi, +4 more
- 01 Mar 1981 - 
TL;DR: The acquisition of pneumonia by a low-risk patient should alert the physician to the possibility of a potentially preventable nosocomial infection.
Journal Article

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.

D W Branch, +4 more
- 01 Oct 1992 - 
TL;DR: Pregnancy in women with antiphospholipid syndrome appears to be improved by treatment, but fetal loss may occur despite treatment, and thrombosis prophylaxis should be considered in these patients.
Journal ArticleDOI

Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic Arthritis

Robert F. Willkens, +12 more
- 01 Apr 1984 - 
TL;DR: Methotrexate was superior to placebo only in physician assessment of arthritis activity and in improvement of the amount of skin surface area with psoriasis.